Moreover, inhibition of NF-κB by various genetic manipulations including the expression of IκBα or IκB kinase (IKK) mutants attenuated growth of HER2/neu receptor-initiated mammary tumors in MMTV-ErbB2/neu transgenic mice [10]–[12]. The gene discussed is NFKB1; the disease is breast cancer.